Uxin Limited Sponsored ADR (NASDAQ:UXIN – Get Free Report) was down 7.4% during trading on Tuesday . The stock traded as low as $3.85 and last traded at $3.7310. Approximately 427,260 shares were traded during trading, an increase of 14% from the average daily volume of 375,259 shares. The stock had previously closed at $4.03.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on UXIN shares. Wall Street Zen upgraded Uxin from a “sell” rating to a “hold” rating in a report on Saturday, December 20th. Weiss Ratings started coverage on shares of Uxin in a report on Thursday, October 16th. They set a “sell (e+)” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft set a $4.50 price objective on shares of Uxin and gave the company a “buy” rating in a report on Monday, December 22nd. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Uxin presently has an average rating of “Hold” and an average price target of $4.50.
View Our Latest Report on Uxin
Uxin Trading Down 6.0%
Uxin (NASDAQ:UXIN – Get Free Report) last posted its earnings results on Thursday, December 18th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $123.51 million for the quarter.
Uxin Company Profile
Uxin Limited is a China-based online and offline used car e-commerce platform that connects vehicle buyers and sellers through an integrated digital marketplace. Headquartered in Beijing, the company operates a network of physical used-car malls alongside its proprietary online platform, enabling customers to browse, inspect and purchase pre-owned vehicles with transparency and convenience.
The company’s core business activities encompass sourcing, quality assurance and distribution of used vehicles.
Further Reading
- Five stocks we like better than Uxin
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- YDES Could Be 2026’s Biotech Breakthrough
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Uxin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uxin and related companies with MarketBeat.com's FREE daily email newsletter.
